Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus carriage at hospital admission

Infection Control and Hospital Epidemiology

Volumn 28, Issue 11, 2007, Pages 1314-1317

  Casas, Irma ^a   Sopena, Nieves ^a   Esteve, Maria ^a   Quesada, Maria Dolores ^a   Andre's, Isabel ^a   Matas, Lourdes ^a   Blanco, Silvia ^a   Pedro Botet, Maria Luisa ^a   Caraballo, Montse ^a   Ausina, Vicente ^a   Sabrià, Miquel ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM CARRIER; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DRUG SENSITIVITY; FEMALE; GENOTYPE; HOSPITAL ADMISSION; HUMAN; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; RISK FACTOR;

AGED; CARRIER STATE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICAL RECORDS; METHICILLIN RESISTANCE; MIDDLE AGED; PATIENT ADMISSION; PREVALENCE; RISK FACTORS; SPAIN; STAPHYLOCOCCUS AUREUS;

EID: 35348983345     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/520738     Document Type: Article

References (21)

1. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005; 40:562-573.
2. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. New Engl J Med 2005; 352:1436-1444.
3. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998; 27:543-550.
4. Sabrià-Leal M, Morthland VH, Pedro-Botet ML, et al. Molecular epidemiology for local epidemic outbreaks of methicillin resistant Staphylococcus aureus: the need for several methods. Eur J Epidemiol 1994; 10:325-330.
5. Sopena N, Sabria M, Pedro-Botet ML, et al. Impact of control measures on the course of an outbreak of methicillin-resistant Staphylococcus aureus [in Spanish]. Med Clin (Barc) 1997; 108:401-404.
6. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Test: 7th ed. Villanova, PA: National Committee for Clinical and Laboratory Standards; 2002:MO2-A7.
7. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239.
8. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36:131-139.
9. Harbarth S, Sax H, Fankhauser-Rodriguez C, Schrenzel J, Agostinho A, Pittet D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med 2006; 119:275.
10. Furuno JP, Harris AD, Wright MO, et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. Am J Infect Control 2004; 32:436-440.
11. Davis KA, Steward JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39:776-782.
12. Fishbain JT, Lee JC, Nguyen HD, et al. Nosocomial transmission of methicillin-resistant Staphylococcus aureus: a blinded study to establish baseline acquisition rates. Infect Control Hosp Epidemiol 2003; 24:415-421.
13. Fukuda M, Tanaka H, Kajiwara Y, et al. High-risk populations for nasal carriage of methicillin-resistant Staphylococcus aureus. J Infect Chemother 2004; 10:189-191.
14. Troillet N, Carmeli Y, Samore M, et al. Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol 1998; 19:181-185.
15. Lucet JC, Grenet K, Armand-Lefevre L, et al. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol 2005; 26:121-126.
16. Eveillard M, Mortier E, Lancien E, et al. Consideration of age at admission for selective screening to identify methicillin-resistant Staphylococcus aureus carriers to control dissemination in a medical ward. Am J Infect Control 2006; 34:108-113.
17. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34:425-433.
18. Lucet JC, Chevret S, Durand-Zaleski I, Chastang C, Régnier B, for the Multicenter Study Group. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003; 163:181-188.
19. Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005; 41:159-166.
20. Jernigan JA, Pullen AL, Partin C, Jarvis WR. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population. Infect Control Hosp Epidemiol 2003; 24:445-450.
21. Sopena N, Garcia-Nunez M, Prats R, et al. Appearance of methicillin-resistant Staphylococcus aureus (MRSA) sensitive to gentamicin in a hospital with a previous endemic distinct MRSA. Eur J Epidemiol 2001; 17:317-321.